Topics in Drug Testing from Quest Diagnostics

Topics in Drug Testing from Quest Diagnostics header image 1

Hosts & Show

February 14, 2020

Topics in Drug Testing features three top toxicologists from Quest Diagnostics with clear and up-to-date information about important issues in drug monitoring today.  These high-energy experts entertain listeners while cutting through many of the misunderstandings about drug testing and monitoring issues. 

With real-life examples and backed by data from millions of drug tests run each year, Topics in drug testing provides helpful insights that will inform your clinical decisions.  

Quest Diagnostics has been a leader and trusted partner in diagnostic testing for more than 50 years. One of the largest labs in the world, Quest offers a broad and diverse range of drug tests to identify prescribed, nonprescribed, and illicit drugs.

Our presenters include:

host-gudin.jpgJeffrey Gudin, MD; Executive Director, Medical Affairs, Drug Monitoring & Toxicology

Dr Gudin is an active speaker and advisor whose clinical and research interests include postoperative pain management; opioid abuse, and potential solutions; and increasing clinical awareness of pain assessment and risk management. Dr Gudin is an attending physician in the Department of Anesthesiology at Englewood Hospital and Medical Center in New Jersey, and associate clinical professor of anesthesiology at Rutgers-NJ school of medicine.  Board-certified in pain management, addiction medicine, and hospice and palliative medicine, Dr Gudin is also a medical acupuncturist. He serves as co-Editor-at-Large for Practical Pain Management. 

host-kain.jpgJack Kain, PharmD; Director of Medical Affairs, Medical Science Liaison

Dr Kain has served as a consultant, clinical toxicologist and medical science liaison for multiple toxicology laboratories. He currently works alongside the Quest Diagnostics’ Drug Monitoring & Toxicology team.  Dr Kain has developed solutions that identify and incorporate drug-drug interaction analytics into drug testing platforms. He is a frequent presenter at clinical and academic conferences and also serves on numerous committees, including the Addiction Treatment Advisory Group for the Academy of Managed Care Pharmacy. 

Moderating the programs will be Frank Samarro, director of clinical segment marketing for the Quest Diagnostics Drug Monitoring franchise.  Frank adds 15 years of professional and clinical marketing and communications experience with considerable experience in the pain management and Medication-Assisted Treatment therapeutic areas.

Drs Gudin and Kain are backed up with extensive expertise in diagnostics. Quest Diagnostics has more than 650 MDs, PhDs, and toxicologists across the country who are available to assist with results interpretation through our dedicated toxicology hotline. For assistance with clinical drug monitoring results, call 1.877.40.RXTOX (1.877.407.9869).